Invention Grant
- Patent Title: Pharmaceutical composition
-
Application No.: US16627061Application Date: 2018-06-29
-
Publication No.: US11344535B2Publication Date: 2022-05-31
- Inventor: Yuki Kuroiwa , Akito Minamizono
- Applicant: KOWA COMPANY, LTD.
- Applicant Address: JP Nagoya
- Assignee: KOWA COMPANY, LTD.
- Current Assignee: KOWA COMPANY, LTD.
- Current Assignee Address: JP Nagoya
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JPJP2017-128406 20170630
- International Application: PCT/JP2018/024882 WO 20180629
- International Announcement: WO2019/004447 WO 20190103
- Main IPC: A61K31/423
- IPC: A61K31/423 ; A61K9/14 ; A61K9/20 ; A61K9/48
Abstract:
Provided is a pharmaceutical composition containing pemafibrate, a salt thereof or a solvate thereof and having excellent storage stability. The pharmaceutical composition is provided to contain pemafibrate, a salt thereof or a solvate thereof, wherein a pH value of a solution produced by dissolving or dispersing the pharmaceutical composition in water is 7 or more.
Public/Granted literature
- US20200222370A1 PHARMACEUTICAL COMPOSITION Public/Granted day:2020-07-16
Information query
IPC分类:
